HK Stock Market Move | HAIZHI TECH GP (02706) rose more than 11% in early trading as the Ministry of Industry and Information Technology launches a special initiative to nurture AI application service providers.
Haizhi Technology Group (02706) rose over 11% in the early trading session. As of the time of writing, it increased by 10.31%, reaching HKD 61.0, with a transaction volume of HKD 106 million.
HAIZHI TECH GP (02706) rose over 11% in early trading. As of the time of publication, it was up 10.31%, priced at HKD 61.0, with a trading volume of HKD 106 million.
In news, the Ministry of Industry and Information Technology recently issued a notice to organize special actions for cultivating artificial intelligence application service providers. The notice specifies that by the end of 2026, the number of service providers in the national resource pool will exceed 2,000; by the end of 2027, this number will be no less than 3,000, supporting the formation of an artificial intelligence application service ecosystem characterized by collaborative elements, seamless supply chains, and comprehensive scenario coverage.
HAITONG INT'L released a research report stating that HAIZHI Technology's performance in the first half of the year further validated the revenue growth and high gross profit margin of the Agent business, as well as the cross-selling logic of upgrading Graph clients to Agent services; the management maintains a positive outlook for the full year. If customer conversion and ARPU continue to exceed current assumptions in the second half of the year, there remains upwards potential for the company's revenue and profit forecasts.
Related Articles

How to choose AI applications in Hong Kong stocks? DIAGENS-B (02526): A rare vertical AI target with high growth and strong barriers.

Valuation at $2 trillion! Anthropic may become the largest IPO in history, starting its roadshow in October and going public before the mid-term elections in November.

Astrazeneca PLC Sponsored ADR (AZN.US) has received accelerated approval from the FDA for a new breast cancer drug, and Wall Street estimates that sales could reach $2.3 billion by 2032.
How to choose AI applications in Hong Kong stocks? DIAGENS-B (02526): A rare vertical AI target with high growth and strong barriers.

Valuation at $2 trillion! Anthropic may become the largest IPO in history, starting its roadshow in October and going public before the mid-term elections in November.

Astrazeneca PLC Sponsored ADR (AZN.US) has received accelerated approval from the FDA for a new breast cancer drug, and Wall Street estimates that sales could reach $2.3 billion by 2032.

RECOMMEND





